Brief: Lipidor To Start Phase III Clinical Study Of AKP02
27/09/2021 10:07
Sept 27 (Reuters) - Lipidor AB LIPI.ST :
* LIPIDOR ANNOUNCES APPROVAL TO START PHASE III CLINICAL
STUDY OF
DRUG CANDIDATE AKP02 FOR TREATMENT OF PSORIASIS
Source text for Eikon: ID:nWkr5tc9NF
Further company coverage: LIPI.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))